Document is current
Any future updates will be listed below
-
Authors
Senghor, Bruno https://orcid.org/0000-0003-4292-0713
Mathieu-Begné, Eglantine
Rey, Olivier
Doucouré, Souleymane
Sow, Doudou
Diop, Bocar
Sène, Mariama
Boissier, Jérôme
Sokhna, Cheikh
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04635553 at ClinicalTrials.govDocuments that mention this clinical trial
Urogenital schistosomiasis in three different water access in the Senegal river basin: prevalence and monitoring praziquantel efficacy and re-infection levels
https://doi.org/10.1186/s12879-022-07813-5
-
Funding
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (TMA2018CDF-2370)
- License Information
-
More Information
Article History
Received: 14 March 2022
Accepted: 26 October 2022
First Online: 29 December 2022
Declarations
:
: The current study was approved by the Senegalese National Ethics Committee (reference No. 000073/MSAS/DPRS/CNERS) and received administrative authorisation from the Directorate of Planning, Research and Statistics/MSAS (reference: 392//MSAS/DPRS/DR) and the academic inspection authorities in the Saint-Louis region (reference: 834/IA/SG/SEPA/oc). The objectives of the study were explained to the administrative and health authorities before starting the study. In each village, community meetings to explain the study took place in the presence of the local nurse, the chief of the village, the director of the school, community representatives, and the parents or legal guardians of the children. Before subjects were selected, written informed consent was obtained from their parents or legal guardians.
: Not applicable.
: The authors have no conflicts of interest to declare.
